Abstract:Telomere shortens and telomerase activation was found both in malignant hematological cell line cells and leukemia samples. However, the mechanism of telomerase activation is unclear. The regulation of telomerase activity could be explained by many aspects, telomere binding protein is one of the new one. Pinx1 is an inhibitor of telomerase activity. Overexpression of Pinx1 inhibits telomerase activity, shortens telomeres, and induces crisis, whereas depletion of endogenous Pinx1 increases telomerase activity and elongates telomeres. However, how does Pinx1 act on telomerase in malignant tumor cells is not clear. In this study, we detected the expression of telomerase inhibitor Pinx1 in acute leukemia cells and during the differentiation of acute promyelocytic leukemia cells to realize its effect on telomerase activity and the probable mechanism inside. 30 acute leukemia cases were all enrolled at their first diagnose, 17 samples were of acute non-lymphocytic leukemia (ANLL) while 13 of acute lymphoblastic leukemia (ALL). Realtime quantitative PCR with fluorescence probe hybridization was used to measure expression of Pinx1 and hTERT mRNA in acute leukemia cells and during differentiation of NB4 cells induced by ATRA. NB4 cells at the initial concentration of 1×105/ml were treated with 1uM ATRA. Cells were collected at 5 time points as 0h, 12h, 24h, 48h and 72h. Pinx1 mRNA expression in acute leukemia samples(0.00312, 5.42×10−4~0.024)is significantly higher than that in normal bone marrow mononuclear cells(7.89×10−4, 0~0.00863)(P<0.01=. Both its expression in ANLL cells(0.00296, 0.00103~0.0182)( P<0.05=and ALL cells(0.00327, 5.42×10−4~0.024) (P<0.05= were higher than that in normal bone marrow mononuclear cells. The expression of Pinx1 mRNA had significant positive correlation with hTERT mRNA expression (r=0.296, P<0.05=. Pinx1 mRNA expression decreased during NB4 cell differentiation, its expression was positive correlated with hTERT mRNA expression (r=0.900, P<0.05=. Why telomerase was activated in malignant tumor cells is unclear yet. It was considered to be activated after telomere length shortened to an extent. So telomere binding proteins may play an important role in telomerase activation. Pinx1 was regarded as a negative regulator of telomerase. It was reported that Pinx1 expression was significantly reduced in many human tumor samples including liver, prostate, colon and lung carcinoma. But some studies showed Pinx1 expression has no significant change in human gastrointestinal tract carcinoma and in human hepatocellular carcinoma. We found Pinx1 expression increased in acute leukemia cells and decreased during NB4 cell differentiation, positive correlated with hTERT mRNA expression As Pinx1 is the only telomere binding protein that can bind to hTERT directly, we hypothesized that the variation of Pinx1 mRNA expression during differentiation acted as a negative feedback to hTERT for stabilization of telomerase activity. When hTERT levels increased, more Pinx1 would be bound with hTERT resulting in reduced free Pinx1 protein in cells. This in turn caused compensate increase in Pinx1 transcription. When hTERT decreased, amount of free Pinx1 protein would increase and result in decrease in Pinx1 mRNA expression. So Pinx1's variation may be a subsequent reaction induced by that of hTERT during differentiation, though the exact mechanism needs further studies.

Molecular analysis of PinX1 in medulloblastomas.

Expression and Clinical Significance of PinX1 Gene in Non-small Cell Lung Cancer

High SNP concentrations on the X-chromosome suggest prospective gene targets FTX, CROCCP1, TTC3P1, KANTR, and AP2B1P in medulloblastoma

The Depletion of PinX1 Involved in the Tumorigenesis of Non-Small Cell Lung Cancer Promotes Cell Proliferation Via P15/cyclin D1 Pathway

Analysis of loss of heterozygosity on chromosomes 10q, 11, and 16 in medulloblastomas

PinX1 suppresses tumorigenesis by negatively regulating telomerase/telomeres in colorectal carcinoma cells and is a promising molecular marker for patient prognosis.

Study on Expression of Telomerase Inhibitor Pinx1 in Leukemia Cells and Its Correlation with Telomerase Activity.

PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis

Expression of Telomerase Inhibitor Pinxl in Leukemia Cells and Its Correlation with Telomerase Activity

Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor

Integrated in Silico–In Vitro Identification and Characterization of the SH3-Mediated Interaction Between Human PTTG and Its Cognate Partners in Medulloblastoma

Pinx1 Without the G-Patch Motif Suppresses Proliferation, Induces Senescence, but Does Not Inhibit Telomerase Activity in Colorectal Cancer Sw480 Cells

Pinx1 Is A Novel Microtubule-Binding Protein Essential For Accurate Chromosome Segregation

Genetic Alterations of DLC1 in Medulloblastoma and Primitive Neuroectodermal Tumor

Decreased Expression of Pinx1 Protein is Correlated with Tumor Development and is A New Independent Poor Prognostic Factor in Ovarian Carcinoma

Identification of A Minimal Region of Genetic Loss at 8p23.1 and Investigation of Gata4 As A Candidate Tumor Suppressor Gene in Medulloblastoma

The telomere/telomerase binding factor PinX1 is a new target to improve the radiotherapy effect of oesophageal squamous cell carcinomas.

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Suppression of PinX1 Resulted in Telomere Dysfunction and Enhanced Radiosensitivity in Osteosarcoma Cell Lines.

Identification of a Novel Homozygous Deletion Region at 6q23.1 in Medulloblastomas Using High-Resolution Array Comparative Genomic Hybridization Analysis